After Uzbekistan Health Ministry alleged Indian company Marion Biotech cough syrup responsible for the death of 18 children, a joint inspection of the NOIDA facility of the manufacturer, Marion Biotech, was carried out by UP Drug Control and CDSCO team.
The Central Drugs Standard Control Organisation (CDSCO) is in regular contact with the national drug regulator of Uzbekistan regarding the matter.
“Immediately on receipt of the information, joint inspection of the NOIDA facility of the manufacturer, Marion Biotech, was carried out by UP Drug Control and CDSCO team and further action as appropriate would be initiated based on the inspection report”, said union health ministry on Thursday.
The samples of the cough syrup have been taken from the manufacturing premises and sent to Regional Drugs Testing Laboratory (RDTL), Chandigarh for testing. Meanwhile, Marion Biotech Pharma company has said that it has sent samples of the said cough syrup for testing and has also halted the production of the product. Marion Biotech is a licensed manufacturer and holds license for manufacturing of Dok1 Max syrup and Tablet for export purpose granted by Drugs Controller, Uttar Pradesh.
Paras Health has launched Paras Medi Clinic, a community-focused healthcare initiative and Gurugram’s neighbourhood clinic…
In a unique case of showing spirit of Raksha Bandhan, a 24-year-old man has saved…
The national capital reported 138 H1N1 cases in the last 24 hours, taking the cumulative…
The Central Government has imposed restrictions on the manufacture, sale, and distribution of all fixed-dose…
Addressing the 2nd ICC Medical Education Forum, organised by the Indian Chamber of Commerce (ICC) in association…
The National Medical Commission has proposed a centrally generated unique identification number for every registered…